Next Article in Journal
Exogenous C2 Ceramide Suppresses Matrix Metalloproteinase Gene Expression by Inhibiting ROS Production and MAPK Signaling Pathways in PMA-Stimulated Human Astroglioma Cells
Next Article in Special Issue
EIYMNVPV Motif is Essential for A1CF Nucleus Localization and A1CF (-8aa) Promotes Proliferation of MDA-MB-231 Cells via Up-Regulation of IL-6
Previous Article in Journal
pH-Responsive Hyaluronic Acid-Based Mixed Micelles for the Hepatoma-Targeting Delivery of Doxorubicin
Previous Article in Special Issue
Notch Signaling in Pancreatic Development
Article

Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer

1
Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Grunwaldzka 6 Street, 60-780 Poznan, Poland
2
Department of Thoracic Surgery, Poznan University of Medical Sciences, Szamarzewskiego 62 Street, 60-569 Poznan, Poland
*
Author to whom correspondence should be addressed.
Academic Editor: William Chi-shing Cho
Int. J. Mol. Sci. 2016, 17(4), 410; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17040410
Received: 13 January 2016 / Revised: 7 March 2016 / Accepted: 14 March 2016 / Published: 31 March 2016
(This article belongs to the Special Issue Molecular Classification of Human Cancer: Diagnosis and Treatment)
Due to high mortality rates of lung cancer, there is a need for identification of new, clinically useful markers, which improve detection of this tumor in early stage of disease. In the current study, serum peptide profiling was evaluated as a diagnostic tool for non-small cell lung cancer patients. The combination of the ZipTip technology with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) for the analysis of peptide pattern of cancer patients (n = 153) and control subjects (n = 63) was presented for the first time. Based on the observed significant differences between cancer patients and control subjects, the classification model was created, which allowed for accurate group discrimination. The model turned out to be robust enough to discriminate a new validation set of samples with satisfactory sensitivity and specificity. Two peptides from the diagnostic pattern for non-small cell lung cancer (NSCLC) were identified as fragments of C3 and fibrinogen α chain. Since ELISA test did not confirm significant differences in the expression of complement component C3, further study will involve a quantitative approach to prove clinical utility of the other proteins from the proposed multi-peptide cancer signature. View Full-Text
Keywords: peptide profiling; non-small cell lung cancer; MALDI-TOF-MS; ZipTip enrichment peptide profiling; non-small cell lung cancer; MALDI-TOF-MS; ZipTip enrichment
Show Figures

Graphical abstract

MDPI and ACS Style

Klupczynska, A.; Swiatly, A.; Hajduk, J.; Matysiak, J.; Dyszkiewicz, W.; Pawlak, K.; Kokot, Z.J. Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer. Int. J. Mol. Sci. 2016, 17, 410. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17040410

AMA Style

Klupczynska A, Swiatly A, Hajduk J, Matysiak J, Dyszkiewicz W, Pawlak K, Kokot ZJ. Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2016; 17(4):410. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17040410

Chicago/Turabian Style

Klupczynska, Agnieszka, Agata Swiatly, Joanna Hajduk, Jan Matysiak, Wojciech Dyszkiewicz, Krystian Pawlak, and Zenon J. Kokot 2016. "Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer" International Journal of Molecular Sciences 17, no. 4: 410. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms17040410

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop